Jubilant Ingrevia Limited (JUBLINGREA)

Loading page…

Jubilant Ingrevia Limited (JUBLINGREA) · mywealthgrid

About

Jubilant Ingrevia is a specialty chemicals company within the Materials sector, with a market cap of ₹11,739.61 Cr. The company serves pharmaceutical, agricultural, and industrial customers with specialty chemical products. Recent quarters show revenue recovery to ₹1,300.27 Cr (Q2 FY26), with net profit reaching ₹126.22 Cr.

Face value: ₹1

Market cap

₹10,163 Cr

P/E

32.9×

P/B

3.2×

Dividend yield

1.2%

ROE

9.2%

ROCE

11.5%

Debt / equity

0.25

OPM

12.9%

EPS (TTM)

₹19.6

Book value

₹198.2

52-week high

—

52-week low

Key insights

Company research notes and source-linked reviews

Key risks

PE 38.04 vs ROE 9.18%: valuation elevated relative to earnings generation; verify growth visibility required to justify
Earnings volatility: net profit ₹44–₹126 Cr across recent quarters; clarify if cyclical, project-driven, or structural
Operational margin range: OPM spans 9.6% to 17.07%, indicating commodity price or input cost sensitivity
Regulatory exposure: chemicals sector faces environmental and compliance pressures; assess capex intensity

Generated analysis · source review pending

Growth drivers

Revenue momentum: Q2 FY26 ₹1,300.27 Cr up 28% from Q4 FY25 low of ₹1,018.01 Cr; verify if segment-driven and sustainable
Profitability peak: ₹126.22 Cr net profit (Q2 FY26) highest in recent eight quarters; clarify if new run-rate or cyclical high
Margin expansion window: Jun 2026 OPM 17.07% vs. 12.92% average; investigate if structural operational gains or temporary
Financial capacity: D/E 0.25 provides flexibility for strategic capex or acquisitions; verify management investment plans

Generated analysis · source review pending

1,364 historical price candles were omitted because the exchange source has not been verified.

₹638.0-0.2%1Y

Quick read

rule-based

Pros

+Profit CAGR of 38.6% over the last 5 years
+Revenue CAGR of 45% over the last 5 years
+Dividend payout of 38.7% of profit

Cons

−Low return on equity of 8.3% (3-yr avg)

Research score

Structured signal from quality, growth, valuation and momentum.

48/100

Business quality: 42
Growth: 50
Valuation: 53

Revenue & net profit

₹ crore, by fiscal year

RevenuePAT

Margins

% of revenue, by fiscal year

OPMPAT margin

Peers

Comparable companies from the narrowest available industry classification.

Part ofNIFTY SMALLCAP 250 NIFTY MIDSMALLCAP 400 NIFTY 500 NIFTY TOTAL MARKET

Screen this industry Compare top 5 side-by-side

Company	Mkt Cap	EV	Revenue	EBITDA	OPM	PAT	NPM	ROCE	ROE	WC Days
Gujarat Fluorochemicals LimitedFLUOROCHEMFLUOROCHEM	₹47,713 Cr	₹49,912 Cr	₹5,303 Cr	₹1,375 Cr	25.8%	₹615 Cr	11.5%	11.1%	7.6%	401
Navin Fluorine International LimitedNAVINFLUORNAVINFLUOR	₹41,740 Cr	₹42,967 Cr	₹3,634 Cr	₹1,232 Cr	32.6%	₹790 Cr	20%	21.6%	20.1%	61
Aether Industries LimitedAETHERAETHER	₹22,161 Cr	₹22,603 Cr	₹1,224 Cr	₹384 Cr	31.3%	₹235 Cr	19.8%	13.2%	9.4%	330
Atul LimitedATULATUL	₹17,231 Cr	₹17,411 Cr	₹6,643 Cr	₹1,189 Cr	16.4%	₹704 Cr	11%	14.1%	11.5%	70
Aarti Industries LimitedAARTIINDAARTIIND	₹16,869 Cr	₹21,790 Cr	₹9,012 Cr	₹1,337 Cr	14.1%	₹531 Cr	5.1%	8.8%	7.3%	54
Fine Organic Industries LimitedFINEORGFINEORG	₹15,752 Cr	₹15,797 Cr	₹2,472 Cr	₹535 Cr	20.4%	₹438 Cr	17.6%	21.6%	16.8%	113
Basf India LimitedBASFBASF	₹14,796 Cr	₹14,796 Cr	₹16,177 Cr	₹952 Cr	4.4%	₹643 Cr	2.8%	14%	11.1%	40
Privi Speciality Chemicals LimitedPRIVISCLPRIVISCL	₹13,970 Cr	₹14,980 Cr	₹2,671 Cr	₹666 Cr	25.2%	₹342 Cr	12.4%	27.7%	25.2%	158
Sudeep Pharma LimitedSUDEEPPHRMSUDEEPPHRM	₹13,546 Cr	₹13,694 Cr	₹676 Cr	₹233 Cr	34.6%	₹133 Cr	27.1%	31.1%	25.2%	366
Anupam Rasayan India LimitedANURASANURAS	₹13,243 Cr	₹15,058 Cr	₹2,535 Cr	₹563 Cr	22.2%	₹175 Cr	9.4%	9.1%	5.5%	377
Vinati Organics LimitedVINATIORGAVINATIORGA	₹12,528 Cr	₹12,528 Cr	₹2,381 Cr	₹665 Cr	29.4%	₹448 Cr	19.9%	18.8%	14.9%	152
Elantas Beck India LimitedELANTASELANTAS	₹10,644 Cr	₹10,644 Cr	₹778 Cr	₹147 Cr	20.3%	₹136 Cr	17.4%	20.6%	15.8%	70

Loading peers…

Financials

Reported profit and loss, balance sheet, cash flow and growth history.

Annual Quarterly

Consolidated Standalone

Consolidated figures · ₹ crore

₹ Cr	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	684	684	4,949	4,773	4,136	4,178	4,388
COGS	354	370	2,794	2,582	2,143	2,107	2,295
Gross profit	330	314	2,155	2,191	1,993	2,070	2,093
	-383	197	1,323	1,644	1,572	1,551	1,526
	713	117	832	547	421	519	567
OPM %	104.3%	17.1%	16.8%	11.5%	10.2%	12.4%	12.9%
Depreciation	22	22	123	122	136	158	175
Interest	7	7	31	22	53	56	49
	16	-10	31	33	35	38	27
Profit before tax	-0	77	709	437	268	344	370
Tax	—	23	232	129	85	92	92
Tax %	—	29.8%	32.8%	29.6%	31.7%	26.9%	24.8%
	-0	54	477	308	183	251	278
PAT margin %	-0%	8%	9.6%	6.4%	4.4%	6%	6.3%
EPS (₹)	-3.3	20.8	30	19.3	11.6	15.9	17.6
EPS adjusted (₹)	—	3.4	30	19.3	11.6	15.9	17.6
	—	1.7%	16.7%	25.9%	43.3%	31.5%	28.4%
Annual report	—	Annual report for Mar 2021	Annual report for Mar 2022	Annual report for Mar 2023	Annual report for Mar 2024	Annual report for Mar 2025	Annual report for Mar 2026

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity capital	16	16	16	16	16	16
Reserves	1,907	2,417	2,650	2,722	2,911	3,110
	546	229	397	733	764	792
	910	1,135	1,196	1,261	1,341	1,566
Total equity & liabilities	3,379	3,797	4,259	4,732	5,032	5,484
	1,756	1,755	1,846	2,497	2,581	3,183
CWIP	63	169	525	331	525	154
Investments	50	6	8	16	37	33
	1,509	1,867	1,880	1,888	1,889	2,113
Total assets	3,379	3,797	4,259	4,732	5,032	5,484

Segment results

As reported in NSE results XBRL. Segment result is before tax and finance costs. ROCE uses that annual result divided by segment assets less liabilities.

Source XBRL ↗

Latest reported period · 31 Mar 2026 · ₹ crore

Segment	Revenue	Result	Assets	Liabilities	Capital employed	ROCE %
Speciality Chemicals	2,214.26	410.38	2,954.02	646.27	2,307.75	17.78
Chemical Intermediates	1,667.98	18.91

Loading financials…

Ratios

Annual operating, return, leverage and working-capital ratios.

Consolidated Standalone

Consolidated figures

Ratio	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	48.3%	45.9%	43.5%	45.9%	48.2%	49.6%	47.7%
EBITDA margin %	104.3%	17.1%	16.8%	11.5%	10.2%	12.4%	12.9%
EBIT margin %	101%	13.9%	14.3%	8.9%	6.9%	8.7%	8.9%
PAT margin %	-0%	8%	9.6%	6.4%	4.4%	6%	6.3%
Working capital
Receivable days	—	251	43	39	50	53	65
Inventory days	—	601	119	146	160	163	140
Payable days	—	685	104	113	131	141	150
NWC days	—	167	58	72	80	75	55
Leverage
Current ratio	—	1.59	1.68	1.54	1.38	1.32	1.29
Debt to EBITDA	—	4.66	0.27	0.73	1.74	1.47	1.4
Debt to equity	—	0.28	0.09	0.15	0.27	0.26	0.25
Interest coverage	94.7	13.3	23.9	21.2	6.1	7.2	8.8
Asset turnover	—	0.2	1.3	1.12	0.87	0.83	0.8
Return ratios
Return on assets %	—	1.6%	12.6%	7.2%	3.9%	5%	5.1%
Return on capital employed %	—	3.9%	28.3%	15.7%	9.8%	11.3%	11.5%
Return on equity %	—	2.8%	19.6%	11.5%	6.7%	8.6%	8.9%

Derived from reported annual statements. ROCE uses EBIT over capital employed (total assets less current liabilities). Day counts average the opening and closing balance; receivables turn on revenue, inventory and payables on cost of goods sold.

Loading ratios…

Shareholding

Quarterly ownership, named holders, insider transactions and disclosed deals.

Quarterly Annual

Every quarter filed · % of equity

Holder (%)	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
	51.47%	51.47%	51.47%	51.47%	51.47%	51.47%	51.47%	45.22%	45.22%	45.22%	45.22%	45.22%
	6.3%	6.35%	6.58%	6.55%	7.22%	6.89%	7.12%	6.96%	5.96%	6.15%	6.49%	6.49%
	9.18%	11.18%	13.61%	14.09%	15.47%	15.99%	15.92%	21.8%	23.04%	24%	24.76%	24.98%
	0%	0%	0%	0%	0%	0%	0%	0%	0.02%	0.02%	0.02%	0.02%
	32.22%	30.17%	27.53%	27.08%	25.07%	24.91%	24.76%	25.3%	24.93%	23.81%	22.52%	22.3%
No. of shareholders	—	—	—	—	—	—	—	—	1,25,749	1,17,529	1,12,696	1,10,949

Promoter holding down 6.25 percentage points since Sep 2023.

13 disclosures

Person	Deal	Shares	Value	Holding	Filed
Jubilant Ingrevia Employees Welfare TrustOther	SellESOP	5,137	₹35.86 L	0.82% → 0.82%	3 Nov 20257(2)
Jubilant Ingrevia Employees Welfare TrustOther	SellESOP	11,932	₹77.56 L

38 deals · 19 Sept 2022 – 13 Jun 2025

Date	Client	Type	Venue	Side	Quantity	Price	Value
13 Jun 2025	KOTAK MAHINDRA MUTUAL FUND	Block	NSE	Buy	44,65,071	₹676.00	₹301.84 Cr
13 Jun 2025	KOTAK MAHINDRA MUTUAL FUND	Bulk	NSE	Buy	44,65,071	₹676.00	₹301.84 Cr
13 Jun 2025	SHYAM SUNDER BHARTIA FAMILY TRUST	Bulk	NSE	Sell	36,23,460	₹676.00	₹244.95 Cr
13 Jun 2025	SHYAM SUNDER BHARTIA FAMILY TRUST	Block	NSE	Sell	36,23,460	₹676.00	₹244.95 Cr
13 Jun 2025	NIKITA RESOURCES PRIVATE LIMITED	Bulk	NSE	Sell	34,14,540	₹676.00	₹230.82 Cr
13 Jun 2025	NIKITA RESOURCES PRIVATE LIMITED	Block	NSE	Sell	34,14,540	₹676.00	₹230.82 Cr
13 Jun 2025	JUBILANT ENPRO PRIVATE LIMITED	Bulk	NSE	Sell	28,27,071	₹676.00	₹191.11 Cr
13 Jun 2025	JUBILANT ENPRO PRIVATE LIMITED	Block	NSE	Sell	28,27,071	₹676.00	₹191.11 Cr
13 Jun 2025	HDFC MUTUAL FUND	Block	NSE	Buy	19,70,000	₹676.00	₹133.17 Cr
13 Jun 2025	HDFC MUTUAL FUND	Bulk	NSE	Buy	19,70,000	₹676.00	₹133.17 Cr

1–10 of 38

1 / 4

Mr. SHYAM SUNDER BHARTIANon-Executive - Non Independent Director-Chairperson related to Promoter
Mr. HARI SHANKER BHARTIAExecutive Director
Ms. SUDHA PILLAINon-Executive - Independent Director
Mr. SUSHIL KUMAR ROONGTANon-Executive - Independent Director
Mr. ARUN SETHNon-Executive - Independent Director
Mr. PRADEEP JYOTI BANERJEENon-Executive - Independent Director
Mr. SIRAJ AZMAT CHAUDHRYNon-Executive - Independent Director
Ms. AMEETA CHATTERJEENon-Executive - Independent Director
Mr. PRIYAVRAT BHARTIANon-Executive - Non Independent Director
Mr. VIJAY KUMAR SRIVASTAVAExecutive Director
Mr. DEEPAK JAINExecutive Director-CEO-MD

Loading shareholding…

F&O

Current futures and options contracts with compact option-chain pages.

Not in the F&O segment

Only about 210 stocks have listed futures and options. Contracts appear here for those, refreshed after each close.

Loading f&o…

Fund holders

Mutual-fund schemes that disclosed a holding in the company.

Portfolio month

Schemes holding

across 11 fund houses

Held by these funds

14.4%

of the company's equity

All mutual funds

22.39%

shareholding pattern, Jun 2026

Portfolios as of

August 2026

compared with July 2026

40 schemes · 11 fund houses

		Shares
Small Cap Fund	DSP Mutual Fund	60.03 L	405.14	1.87%	3.768%	-0
Portfolio of Kotak Small Cap Fund	Kotak Mahindra Mutual Fund	36.29 L	244.95	1.24%	2.278%	-0
Small Cap Fund	Axis Mutual Fund	31.12 L	210.01	0.67%	1.953%	-0
Franklin India Small Cap Fund (Formerly known as Franklin India Smaller Companies Fund) ^	Franklin Templeton Mutual Fund	28.98 L	195.58	1.33%	1.819%	+5 L
Mid Cap Fund	DSP Mutual Fund	28.88 L	194.89	0.93%	1.813%	-5.44 L
India T.I.G.E.R. Fund (The Infrastructure Growth and Economic Reforms Fund)	DSP Mutual Fund	8.17 L	55.11	0.85%	0.513%	-0
Manufacturing Fund	ICICI Prudential Mutual Fund	5.33 L	35.97	0.5%	0.335%	-0
Franklin India Large & Mid Cap Fund (Formerly known as Franklin India Equity Advantage Fund)^	Franklin Templeton Mutual Fund	4.95 L	33.39	0.92%	0.311%	-0

1–8 of 40

1 / 5

Loading fund holders…

Documents

Annual reports, exchange filings, offer documents, ratings and earnings-call material.

Announcements

Loading documents…

Events

Upcoming dates and the company’s corporate-action history.

Loading events…

Announcements

Latest exchange announcements, filings and downloadable documents.

1 month 3 months 6 months 1 year All

27 announcementsExport CSV

1 Oct 2026, 8:08 pmCompany Update

Announcement under Regulation 30 (LODR)-Change in Management

Change in Management PDF

Loading announcements…

Ratio	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Margins
Gross margin %	48.3%	45.9%	43.5%	45.9%	48.2%	49.6%	47.7%
EBITDA margin %	104.3%	17.1%	16.8%	11.5%	10.2%	12.4%	12.9%
EBIT margin %	101%	13.9%	14.3%	8.9%	6.9%	8.7%	8.9%
PAT margin %	-0%	8%	9.6%	6.4%	4.4%	6%	6.3%
Working capital
Receivable days	—	251	43	39	50	53	65
Inventory days	—	601	119	146	160	163	140
Payable days	—	685	104	113	131	141	150
NWC days	—	167	58	72	80	75	55
Leverage
Current ratio	—	1.59	1.68	1.54	1.38	1.32	1.29
Debt to EBITDA	—	4.66	0.27	0.73	1.74	1.47	1.4
Debt to equity	—	0.28	0.09	0.15	0.27	0.26	0.25
Interest coverage	94.7	13.3	23.9	21.2	6.1	7.2	8.8
Asset turnover	—	0.2	1.3	1.12	0.87	0.83	0.8
Return ratios
Return on assets %	—	1.6%	12.6%	7.2%	3.9%	5%	5.1%
Return on capital employed %	—	3.9%	28.3%	15.7%	9.8%	11.3%	11.5%
Return on equity %	—	2.8%	19.6%	11.5%	6.7%	8.6%	8.9%

Date	Category	Subject	Filing
1 Oct 2026, 8:08 pm	Company Update Change in Management	Announcement under Regulation 30 (LODR)-Change in Management	PDF
1 Oct 2026, 7:56 pm	Company Update Acquisition	Announcement under Regulation 30 (LODR)-Updates on Acquisition	PDF
1 Oct 2026, 7:46 pm	Company Update General	Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended (The 'SEBI Listing Regulations')	PDF
1 Oct 2026, 7:41 pm	Others Outcome without intimation	Board Meeting Outcome for Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015, As Amended (The 'SEBI Listing Regulations') - Incorporation Of WOS	PDF
28 Sept 2026, 3:41 pm	Insider Trading / SAST Closure of Trading Window	Closure of Trading Window	PDF
26 Aug 2026, 9:40 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Scrutinizer''s Report	PDF
26 Aug 2026, 9:37 pm	AGM/EGM AGM	Shareholder Meeting / Postal Ballot-Outcome of AGM	PDF
18 Aug 2026, 9:34 pm	Company Update Press Release / Media Release	Announcement under Regulation 30 (LODR)-Press Release / Media Release	PDF

₹ Cr	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
	112	453	462	430	508	524
	-44	-72	-472	-569	-393	-276
	-72	-418	42	144	-129	-155
Net cash flow	-4	-37	32	5	-13	93
Free cash flow	85	223	-19	-138	142	225
CFO / Operating profit %	95.9%	54.4%	84.5%	102.1%	97.9%	92.5%

Jubilant Ingrevia Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Segment results

Ratios

Shareholding

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Announcements

Not in the F&O segment

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

11

1

Segment results

Compounded sales growth

Compounded profit growth

Return on equity

Chemical Intermediates · revenue

Jubilant Ingrevia Limited

About

Key insights

Key risks

Growth drivers

Quick read

Pros

Cons

Research score

Revenue & net profit

Margins

Peers

Financials

Profit & loss

Balance sheet

Segment results

Ratios

Ratio timeline

Shareholding

Quarterly record

Insider dealing

Bulk & block deals

Board and management

F&O

Not in the F&O segment

Fund holders

Documents

Announcements

Events

Announcements

Ratio timeline

Not in the F&O segment

Quarterly record

Insider dealing

Bulk & block deals

Board and management

Announcements

Annual reports

Credit ratings

Investor Presentation and earnings call

Dividends11

Board meetings1

Profit & loss

Balance sheet

Segment results

Cash flow

Compounded returns

Compounded sales growth

Compounded profit growth

Return on equity

Chemical Intermediates · revenue

11

1